The data illustrates key figures on established biotechnology centers worldwide from 2012 to 2016. In 2016, global biotech revenues of publicly traded biotechnology companies from the U.S. and Europe amounted to some 140 billion USD.
Revenues (in billion US$) | 89.7 | 99 | 123.1 | 130.3 | 139.4 |
R&D expenses (in billion US$) | 25.4 | 29.4 | 35.4 | 40.6 | 45.7 |
Net income (in billion US$) | 5.1 | 4.5 | 14.9 | 16.3 | 7.9 |
Number of employees | 165400 | 168010 | 183610 | 178690 | 203210 |
Number of public companies | 602 | 619 | 714 | 680 | 708 |